BIOMAT Database Logo BIOMAT Database Logo

p53 expression in breast cancer related to prognostic factors. 1995

D Ciesielski, and A Dziewulska-Bokiniec, and A Zółtowska, and A Roszkiewicz, and A Kopacz, and J Wojtacki
Department of Immunopathology, Medical University of Gdańsk, Poland.

In this article the results of molecular marker p53 examinations were presented in relation to the following established breast cancer prognostic factors: age, histologic type, histologic grade, lymph node involvement, tumor size as well as estrogen a progesterone receptor status. Twenty one percent of these primary breast cancer specimens exhibited the overexpression of p53 protein. Significant associations were found between p53 overexpression and younger age, high histologic grade and low content of estrogen and progesterone receptors. Identification of p53-positive breast carcinomas potentially represents a clinically useful indicator of breast cancer aggressiveness.

UI MeSH Term Description Entries
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D011379 Prognosis A prediction of the probable outcome of a disease based on a individual's condition and the usual course of the disease as seen in similar situations. Prognostic Factor,Prognostic Factors,Factor, Prognostic,Factors, Prognostic,Prognoses
D011960 Receptors, Estrogen Cytoplasmic proteins that bind estrogens and migrate to the nucleus where they regulate DNA transcription. Evaluation of the state of estrogen receptors in breast cancer patients has become clinically important. Estrogen Receptor,Estrogen Receptors,Estrogen Nuclear Receptor,Estrogen Receptor Type I,Estrogen Receptor Type II,Estrogen Receptors Type I,Estrogen Receptors Type II,Receptor, Estrogen Nuclear,Receptors, Estrogen, Type I,Receptors, Estrogen, Type II,Nuclear Receptor, Estrogen,Receptor, Estrogen
D011980 Receptors, Progesterone Specific proteins found in or on cells of progesterone target tissues that specifically combine with progesterone. The cytosol progesterone-receptor complex then associates with the nucleic acids to initiate protein synthesis. There are two kinds of progesterone receptors, A and B. Both are induced by estrogen and have short half-lives. Progesterone Receptors,Progestin Receptor,Progestin Receptors,Receptor, Progesterone,Receptors, Progestin,Progesterone Receptor,Receptor, Progestin
D001943 Breast Neoplasms Tumors or cancer of the human BREAST. Breast Cancer,Breast Tumors,Cancer of Breast,Breast Carcinoma,Cancer of the Breast,Human Mammary Carcinoma,Malignant Neoplasm of Breast,Malignant Tumor of Breast,Mammary Cancer,Mammary Carcinoma, Human,Mammary Neoplasm, Human,Mammary Neoplasms, Human,Neoplasms, Breast,Tumors, Breast,Breast Carcinomas,Breast Malignant Neoplasm,Breast Malignant Neoplasms,Breast Malignant Tumor,Breast Malignant Tumors,Breast Neoplasm,Breast Tumor,Cancer, Breast,Cancer, Mammary,Cancers, Mammary,Carcinoma, Breast,Carcinoma, Human Mammary,Carcinomas, Breast,Carcinomas, Human Mammary,Human Mammary Carcinomas,Human Mammary Neoplasm,Human Mammary Neoplasms,Mammary Cancers,Mammary Carcinomas, Human,Neoplasm, Breast,Neoplasm, Human Mammary,Neoplasms, Human Mammary,Tumor, Breast
D005260 Female Females
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000328 Adult A person having attained full growth or maturity. Adults are of 19 through 44 years of age. For a person between 19 and 24 years of age, YOUNG ADULT is available. Adults
D000368 Aged A person 65 years of age or older. For a person older than 79 years, AGED, 80 AND OVER is available. Elderly
D016159 Tumor Suppressor Protein p53 Nuclear phosphoprotein encoded by the p53 gene (GENES, P53) whose normal function is to control CELL PROLIFERATION and APOPTOSIS. A mutant or absent p53 protein has been found in LEUKEMIA; OSTEOSARCOMA; LUNG CANCER; and COLORECTAL CANCER. p53 Tumor Suppressor Protein,Cellular Tumor Antigen p53,Oncoprotein p53,TP53 Protein,TRP53 Protein,p53 Antigen,pp53 Phosphoprotein,Phosphoprotein, pp53

Related Publications

D Ciesielski, and A Dziewulska-Bokiniec, and A Zółtowska, and A Roszkiewicz, and A Kopacz, and J Wojtacki
p53 expression in human breast cancer related to survival and prognostic factors: an immunohistochemical study.
May 1991, The Journal of pathology,
D Ciesielski, and A Dziewulska-Bokiniec, and A Zółtowska, and A Roszkiewicz, and A Kopacz, and J Wojtacki
Correlation between p53 expression and other prognostic factors in breast cancer.
January 1998, Romanian journal of morphology and embryology = Revue roumaine de morphologie et embryologie,
D Ciesielski, and A Dziewulska-Bokiniec, and A Zółtowska, and A Roszkiewicz, and A Kopacz, and J Wojtacki
[Prognostic factors related to breast cancer survival].
January 2008, Salud publica de Mexico,
D Ciesielski, and A Dziewulska-Bokiniec, and A Zółtowska, and A Roszkiewicz, and A Kopacz, and J Wojtacki
[Expression of E-cadherin as related to prognostic factors and survivals in breast cancer].
July 1995, Nihon rinsho. Japanese journal of clinical medicine,
D Ciesielski, and A Dziewulska-Bokiniec, and A Zółtowska, and A Roszkiewicz, and A Kopacz, and J Wojtacki
p53 expression as a prognostic marker in inflammatory breast cancer.
September 2004, Clinical cancer research : an official journal of the American Association for Cancer Research,
D Ciesielski, and A Dziewulska-Bokiniec, and A Zółtowska, and A Roszkiewicz, and A Kopacz, and J Wojtacki
Prognostic factors related to response to chemotherapy in metastatic breast cancer.
March 1989, Journal of clinical oncology : official journal of the American Society of Clinical Oncology,
D Ciesielski, and A Dziewulska-Bokiniec, and A Zółtowska, and A Roszkiewicz, and A Kopacz, and J Wojtacki
Tumor-related prognostic factors for breast cancer.
January 1997, CA: a cancer journal for clinicians,
D Ciesielski, and A Dziewulska-Bokiniec, and A Zółtowska, and A Roszkiewicz, and A Kopacz, and J Wojtacki
Relation between p53 overexpression and established prognostic factors in breast cancer.
August 1991, Surgery,
D Ciesielski, and A Dziewulska-Bokiniec, and A Zółtowska, and A Roszkiewicz, and A Kopacz, and J Wojtacki
[Analysis of prognostic factors related to triple-negative breast cancer].
November 2013, Zhonghua wai ke za zhi [Chinese journal of surgery],
D Ciesielski, and A Dziewulska-Bokiniec, and A Zółtowska, and A Roszkiewicz, and A Kopacz, and J Wojtacki
Environmental factors in relation to breast cancer characterized by p53 protein expression.
September 2002, Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology,
Copied contents to your clipboard!